Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Small-molecule natural product sophoricoside reduces peripheral neuropathic pain via directly blocking of NaV1.6 in dorsal root ganglion nociceptive neurons
    Published on 2024-10-16
    2 years ago
  • Sex-specific and developmental effects of early life adversity on stress reactivity are rescued by postnatal knockdown of 5-HT1A autoreceptors
    Published on 2024-10-12
    2 years ago
  • Autism spectrum disorder-like behaviors induced by hyper-glutamatergic NMDA receptor signaling through hypo-serotonergic 5-HT1A receptor signaling in the prefrontal cortex in mice exposed to prenatal valproic acid
    Published on 2024-10-11
    2 years ago
  • Neuroimaging in psychiatry: toward mechanistic insights and clinical utility
    Published on 2024-10-11
    2 years ago
  • Effects of ketamine on GABAergic and glutamatergic activity in the mPFC: biphasic recruitment of GABA function in antidepressant-like responses
    Published on 2024-10-11
    2 years ago
  • Investigating cross-sectional and longitudinal relationships between brain structure and distinct dimensions of externalizing psychopathology in the ABCD sample
    Published on 2024-10-09
    2 years ago
  • Medial prefrontal cortex acetylcholine signaling mediates the ability to learn an active avoidance response following learned helplessness training
    Published on 2024-10-03
    2 years ago
« Previous 1 … 71 72 73 74 75 … 143 Next »
Journal of Psychopharmacology
  • Effects of clozapine treatment on the improvement of substance use disorders other than nicotine in individuals with schizophrenia spectrum disorders: A systematic review and meta-analysis
    Published on 2022-12-12
    4 years ago
  • Common practical questions – and answers – at the British Association for Psychopharmacology child and adolescent psychopharmacology course
    Published on 2022-12-07
    4 years ago
  • Characteristics of poisonings involving ketamine in the United States, 2019–2021
    Published on 2022-12-07
    4 years ago
  • Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression
    Published on 2022-11-26
    4 years ago
  • Regular cannabis use modulates the impact of HIV on the neural dynamics serving cognitive control
    Published on 2022-11-23
    4 years ago
  • Should we be leery of being Leary? Concerns about psychedelic use by psychedelic researchers
    Published on 2022-11-15
    4 years ago
  • Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder
    Published on 2022-11-15
    4 years ago
« Previous 1 … 71 72 73 74 75 … 150 Next »
European Neuropsychopharmacology
  • New biomarkers in mood disorders: Insights from immunopsychiatry and neuroimaging
    Published on 2023-02-13
    3 years ago
  • In vivo serotonin transporter and 1A receptor binding potential and ecological momentary assessment (EMA) of stress in major depression and suicidal behavior
    Published on 2023-02-12
    3 years ago
  • Vortioxetine improves physical and cognitive symptoms in patients with post-COVID-19 major depressive episodes
    Published on 2023-02-08
    3 years ago
  • Initial response to the COVID-19 pandemic on real-life well-being, social contact and roaming behavior in patients with schizophrenia, major depression and healthy controls: A longitudinal ecological momentary assessment study
    Published on 2023-02-03
    3 years ago
  • Higher lymphocyte count associated with larger hippocampal volume and fewer depressive symptoms in drug–na ïve first-episode psychosis
    Published on 2023-01-28
    4 years ago
  • Number needed to treat and number needed to harm: What are they good for?
    Published on 2023-01-27
    4 years ago
  • Multi-omics data integration methods and their applications in psychiatric disorders
    Published on 2023-01-26
    4 years ago
« Previous 1 … 71 72 73 74 75 … 168 Next »

   Pharma Pub